NCT00861796View on ClinicalTrials.gov

Study of CYR-101 in Patients With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions
Schizophrenia
Interventions
DRUG

CYR-101

Experimental arm

DRUG

Placebo

Placebo comparator

Trial Locations (1)

54201

Centre Hospitalier Universitaire de Nancy (CHU), Toul

Sponsors
All Listed Sponsors
lead

Cyrenaic Pharmaceuticals

INDUSTRY